Loading
LP
Longboard Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Kaye Randall, was filed 13 Aug 2024.
Longboard Pharmaceuticals, Inc.: what insiders have been doing
Longboard Pharmaceuticals, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Longboard Pharmaceuticals, Inc. has published a filing in the past twelve months. The most recent one dates from 2 December 2024.
Over the whole record (from 2021), the tally stands at 1 purchase and 9 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
23
Thresholds
n/a
Buy Volume
€2,281
1 ops. · all time
Sell Volume
€91M
9 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
Income statement
Net income-48.4M
Last declaration on 2 December 2024
Declarations23 total
363,740 shares@ US$60.0098.7% of flowCommon StockSEC:0001415889-24-028021:0
30,554 shares@ US$60.0085.0% of flowCommon StockSEC:0001415889-24-028023:0
30,554 shares@ US$6.008.5% of flowCommon StockSEC:0000950170-24-128962:0
80,000 shares0Common StockSEC:0000950170-24-126650:1
12,808 shares@ US$3.12320.2% of flowCommon StockSEC:0000950170-24-126650:0
16,667 shares@ US$59.0422.5% of flowCommon StockSEC:0000950170-24-115026:1
16,667 shares@ US$4.353.3% of flowCommon StockSEC:0000950170-24-115026:0
9,366 shares@ US$30.896.5% of flowCommon StockSEC:0000950170-24-106949:1
4,200 shares@ US$31.813.0% of flowCommon StockSEC:0000950170-24-106949:2
1,200 shares@ US$33.120.9% of flowCommon StockSEC:0000950170-24-106949:3
1,900 shares@ US$34.041.4% of flowCommon StockSEC:0000950170-24-106949:4
16,666 shares@ US$4.353.2% of flowCommon StockSEC:0000950170-24-106949:0
100 shares@ US$20.870.0% of flowCommon StockSEC:0000950170-24-096496:1
16,667 shares@ US$4.351.6% of flowCommon StockSEC:0000950170-24-096496:2
10,476 shares@ US$34.558.2% of flowCommon StockSEC:0000950170-24-096496:3
6,191 shares@ US$35.034.9% of flowCommon StockSEC:0000950170-24-096496:4
2,217 shares@ US$4.200.0% of flowCommon StockSEC:0000950170-24-096499:1
100 shares@ US$24.820.1% of flowCommon StockSEC:0000950170-24-096496:0
Canonical exit: 22 Apr 2024 (T+90)
80,265 shares@ US$3.12321.1% of flowCommon StockSEC:0000950170-24-096499:0
17,920 shares0Common StockSEC:0001209191-24-003027:0
15,090 shares0Common StockSEC:0001209191-24-003026:0
3,978,540 shares@ US$24.25100.0% of flowVoting Common StockSEC:0000078003-24-000012:0
138,000 sharesVoting Common StockSEC:0001209191-21-021798:0
23 of 23 declarations
About Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for neurological disorders. It is listed on NASDAQ under the ticker symbol LBPH.
